This map shows the geographic impact of M Hiratsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hiratsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hiratsuka more than expected).
This network shows the impact of papers produced by M Hiratsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hiratsuka. The network helps show where M Hiratsuka may publish in the future.
Co-authorship network of co-authors of M Hiratsuka
This figure shows the co-authorship network connecting the top 25 collaborators of M Hiratsuka.
A scholar is included among the top collaborators of M Hiratsuka based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M Hiratsuka. M Hiratsuka is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Kameyama, Masao, Shoji Nakamori, H Nakano, et al.. (1997). [A case of huge liver metastasis from colon cancer successfully treated by hepatic intraarterial infusion of low-dose 5-FU].. PubMed. 24(12). 1761–3.1 indexed citations
10.
Kameyama, Masao, Susumu Imaoka, Takeo Yasuda, et al.. (1997). [PyNPase activity in primary and metastatic colorectal cancer].. PubMed. 24(5). 563–7.1 indexed citations
Furukawa, Hiroshi, M Hiratsuka, Tetsuo Iwanaga, et al.. (1996). Treatments for second malignancies after gastrectomy for stomach cancer.. PubMed. 43(7). 194–8.15 indexed citations
13.
Furukawa, Hiroshi, M Hiratsuka, Susumu Imaoka, et al.. (1996). [Adjuvant chemotherapy for advanced gastric cancer].. PubMed. 97(4). 312–6.4 indexed citations
14.
Tsuji, Yasushi, Hiroaki Ohigashi, Osamu Ishikawa, et al.. (1996). [A case of non-resectable pancreatic cancer surviving more than 4 years by intra-arterial infusion chemotherapy with angiotensin-II].. PubMed. 23(11). 1617–20.2 indexed citations
15.
Yasuda, Takushi, T Kabuto, Seiji Ishiguro, et al.. (1995). [Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus].. PubMed. 22(11). 1538–41.8 indexed citations
16.
Ohigashi, Hiroaki, Osamu Ishikawa, Seizo Masutani, et al.. (1991). [Hepatic arterial infusion chemotherapy and loco-regional treatment and irradiation of pancreas tumor in non-resectable pancreas cancer with liver metastases].. PubMed. 18(11). 1776–9.2 indexed citations
17.
Sasaki, Yo, Susumu Imaoka, Seizo Masutani, et al.. (1990). [Chemoembolization for liver metastasis from colorectal cancer].. PubMed. 17(8 Pt 2). 1661–4.3 indexed citations
18.
Kameyama, Masao, M Hiratsuka, H Furukawa, et al.. (1988). [A case of colorectal cancer showing complete response to UFT].. PubMed. 15(6). 1969–72.1 indexed citations
19.
Hiratsuka, M, Ayumi Ogawa, Hiroaki Ohigashi, et al.. (1988). [Dosage and its safety in intraperitoneal high dose mitomycin C administration as postoperative adjuvant therapy for gastric cancer].. PubMed. 23(7). 1574–9.3 indexed citations
20.
Mito, M, H Ebata, Mitsuo Kusano, et al.. (1979). Studies on ectopic liver utilizing hepatocyte transplantation into the rat spleen.. PubMed. 11(1). 585–91.28 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.